Gonorrhoea vaccine - BioPort
Alternative Names: GONOVAX; Neisseria gonorrhoea vaccine - BioPortLatest Information Update: 12 Dec 2006
At a glance
- Originator Emergent BioDefense Operations Lansing
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gonorrhoea
Most Recent Events
- 16 Jun 2003 The assets of Antex Biologics and Antex Pharma have been acquired by BioPort Corporation
- 18 Jul 2002 This vaccine is still in active development
- 19 Oct 2000 New profile